Stay updated on SAGE-217 for Severe Postpartum Depression Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 for Severe Postpartum Depression Clinical Trial page.

Latest updates to the SAGE-217 for Severe Postpartum Depression Clinical Trial page
- Check4 days agoChange DetectedThe site footer now identifies the platform as revision v3.8.0 instead of v3.7.2. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA sitewide NIH notice announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check32 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe study record for NCT04442503 now shows a 403 Forbidden error page, replacing the usual study details. This indicates access restrictions or a permissions issue preventing viewing the record.SummaryDifference18%

- Check53 days agoChange DetectedRevision label on the page updated from v3.6.6 to v3.7.0, indicating an updated release or documentation. This change represents an internal version update rather than a user-facing content modification.SummaryDifference0.0%

- Check67 days agoChange DetectedUpdated the page revision from v3.6.5 to v3.6.6, signaling a new release of the page metadata; no substantive content changes to the study details are reflected in this change.SummaryDifference0.0%

Stay in the know with updates to SAGE-217 for Severe Postpartum Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 for Severe Postpartum Depression Clinical Trial page.